Trials / Completed
CompletedNCT06607237
Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness
Prospective, Single Arm, Open-label Clinical Investigation on the Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Horus Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a pilot, exploratory study to check safety and efficacy of DM-28 device, a new medical device intended to treat moderate to severe ocular dryness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DM-28 | 1 drop in each eye, 4 to 6 times per day |
Timeline
- Start date
- 2024-09-26
- Primary completion
- 2025-01-09
- Completion
- 2025-01-09
- First posted
- 2024-09-23
- Last updated
- 2025-02-13
Locations
2 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT06607237. Inclusion in this directory is not an endorsement.